Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Net Income: 2009-2024

Historic Net Income for Catalyst Pharmaceuticals (CPRX) over the last 16 years, with Dec 2024 value amounting to $163.4 million.

  • Catalyst Pharmaceuticals' Net Income rose 20.28% to $52.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $217.1 million, marking a year-over-year increase of 65.79%. This contributed to the annual value of $163.4 million for FY2024, which is 174.43% up from last year.
  • Per Catalyst Pharmaceuticals' latest filing, its Net Income stood at $163.4 million for FY2024, which was up 174.43% from $59.5 million recorded in FY2023.
  • Over the past 5 years, Catalyst Pharmaceuticals' Net Income peaked at $163.4 million during FY2024, and registered a low of $39.5 million during FY2021.
  • In the last 3 years, Catalyst Pharmaceuticals' Net Income had a median value of $83.1 million in 2022 and averaged $102.0 million.
  • In the last 5 years, Catalyst Pharmaceuticals' Net Income tumbled by 47.35% in 2021 and then soared by 174.43% in 2024.
  • Catalyst Pharmaceuticals' Net Income (Yearly) stood at $75.0 million in 2020, then slumped by 47.35% to $39.5 million in 2021, then surged by 110.42% to $83.1 million in 2022, then declined by 28.34% to $59.5 million in 2023, then spiked by 174.43% to $163.4 million in 2024.